IBM Says Janssen CarePath Platform Is A Patient Support Platform That Offers Savings Options And Other Patient Support; Addresses Data Incident For Janssen CarePath Database
Portfolio Pulse from Happy Mohamed
IBM has announced that the Janssen CarePath platform, a patient support platform offering savings options and other patient support, has experienced a data incident. The platform is related to Janssen, a pharmaceutical company owned by Johnson & Johnson.
September 06, 2023 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IBM's Janssen CarePath platform has experienced a data incident. This could potentially harm IBM's reputation and customer trust.
Data incidents can harm a company's reputation and customer trust, potentially leading to a decrease in customer base and revenue. As IBM is directly responsible for the platform, this incident could negatively impact their stock in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
The data incident on IBM's Janssen CarePath platform could potentially impact Janssen, a subsidiary of Johnson & Johnson, and its parent company.
While the platform is managed by IBM, any negative impact on Janssen could indirectly affect Johnson & Johnson. This could potentially lead to a decrease in customer trust and revenue, negatively impacting their stock in the short term.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 60